<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date earliest event reported)
COMPARE GENERIKS, INC.
(exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
11-3289396
(Commission File Number)(IRS Employer Identification
Number)
300 Oser Avenue, Hauppague, NY 11788
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, Including Area Code:(800)342-6555
(Former name or former address, if changed since last
report)
<PAGE>
Item 1. Changes in Control or Registrant.
On December 9, 1996, David Waldman, a Director of Compare Generiks, Inc.
(the "Company"), sold all of his holdings in Walpac, Inc., the controlling
shareholder of the Company to Delsin Investments, Ltd. Walpac, Inc. owns
5,000,000 shares of Series A Preferred and 800,000 shares of Common Stock of the
Company. As a result of this sale, Delsin Investments, Ltd., through its
ownership of Walpac, Inc. now controls 63.1% of the voting stock of the Company.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly authorized and caused the undersigned to sign this Report on
the Registrant's behalf.
COMPARE GENERIKS, INC.
By: /s/ Thomas A. Keith
-------------------------------
Thomas A. Keith
President
Dated: February 20, 1997
